financetom
Business
financetom
/
Business
/
Barrick Mining Offers Value Amid Rise in Cash Returns, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Barrick Mining Offers Value Amid Rise in Cash Returns, UBS Says
Aug 13, 2025 12:25 PM

03:02 PM EDT, 08/13/2025 (MT Newswires) -- Barrick Mining ( B ) is offering value to investors amid a pickup in cash returns following a broadly in-line Q2 results, UBS said in a Monday note.

"Barrick offers value & long-term growth and potential catalysts/enhanced cash returns from portfolio restructuring," the report said.

The note said a rise in cash returns was a positive with the firm moving to a net cash position triggering a 50% lift in dividend via a "performance dividend" and a lift in the rate of buybacks.

The report also said the "negative" takeaway from the results was a $30/oz upside to unit costs as a result of higher royalties.

UBS kept its buy rating and $26 price target.

Price: 23.80, Change: +0.30, Percent Change: +1.26

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Australian beef farmers say Trump tariffs to boost price of US hamburgers
Australian beef farmers say Trump tariffs to boost price of US hamburgers
Apr 3, 2025
MOSS VALE, Australia (Reuters) - At a cattle auction in Australia's lush Southern Highlands, an auctioneer shouts from a gantry over the din of nearly 2,000 cows waiting to be bought. Prospective owners in felted hats bid up prices with a nod of the head, and business is brisk, despite U.S. President Donald Trump on Thursday imposing a 10% import...
Novartis Gets FDA Accelerated Approval for Vanrafia
Novartis Gets FDA Accelerated Approval for Vanrafia
Apr 3, 2025
04:41 AM EDT, 04/03/2025 (MT Newswires) -- Novartis ( NVS ) said late Wednesday the US Food and Drug Administration granted accelerated approval for Vanrafia to reduce proteinuria in adults with primary immunoglobulin A nephropathy, or IgAN, at risk of rapid disease progression. IgAN is a progressive, rare kidney disease. Data from an ongoing phase III showed that Vanrafia achieved...
Trump stokes trade war as world reels from tariff shock
Trump stokes trade war as world reels from tariff shock
Apr 3, 2025
By Andrea Shalal, Joe Cash and Philip Blenkinsop WASHINGTON/BEIJING/BRUSSELS (Reuters) - President Donald Trump's move to impose sweeping tariffs on U.S. imports on allies and rivals alike sparked threats of retaliation on Thursday, intensifying a global trade war that threatens to stoke inflation and raising fears of recession. The penalties announced on Wednesday unleashed turbulence across world markets and drew...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved